1-{1-[3-(4-acetyl-piperazin-1-yl)-phenyl]-1H-benzoimidazol-5-yl}-ethanone | 206880-03-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并咪唑类
• 英文名称: 1-{1-[3-(4-acetyl-piperazin-1-yl)-phenyl]-1H-benzoimidazol-5-yl}-ethanone
• 英文别名: 5-Acetyl-1-(3-(1-acetyl-4-piperazinyl)-phenyl)-benzimidazole；5-acetyl-1-(3-(1-acetylpiperazinyl-4-yl)phenyl)benzimidazole；5-Acetyl-1-(3-(1-acetylpiperazin-4-yl)phenyl)benzimidazole；1-[1-[3-(4-acetylpiperazin-1-yl)phenyl]benzimidazol-5-yl]ethanone
• CAS: 206880-03-7
• 化学式: C₂₁H₂₂N₄O₂
• 分子量: 362.431
• InChiKey: VQSPFJREGBJESY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  27
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  58.4
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  1-{1-[3-(4-acetyl-piperazin-1-yl)-phenyl]-1H-benzoimidazol-5-yl}-ethanone 在 sodium tetrahydroborate 、 sodium hydride 作用下， 以 甲醇 、 N,N-二甲基甲酰胺 为溶剂， 反应 1.17h， 生成 1-(4-{3-[5-(1-methoxy-ethyl)-benzoimidazol-1-yl]-phenyl}-piperazin-1-yl)-ethanone
  参考文献：
  名称：

  WO2006/111517

  摘要：

  公开号：

文献信息

• Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds
  申请人：——

  公开号：US20030055055A1

  公开（公告）日：2003-03-20

  The present invention relates to novel benzimidazole derivatives, pharmaceutical composition containing these compounds, and methods of treatment therewith. The compounds of the invention are useful in the treatment of central nervous system diseases and disorders, which are responsive to modulation of the GABA receptor complex, and in particular for inducing and maintaining anesthesia, sedation and muscle relaxation, as well as for combating febrile convulsions in children. The compounds of the invention may also be used by veterinarians.

  本发明涉及新型苯并咪唑衍生物，含有这些化合物的药物组合物，以及使用这些化合物进行治疗的方法。本发明的化合物在治疗对GABA受体复合物调节敏感的中枢神经系统疾病和紊乱方面具有用途，特别是用于诱导和维持麻醉、镇静和肌肉松弛，以及用于对抗儿童的热性惊厥。本发明的化合物也可以被兽医使用。
• 1-phenyl-benzimidazole compounds and their use as GABA-a receptor modulators
  申请人：NeuroSearch A/S

  公开号：US06218547B1

  公开（公告）日：2001-04-17

  The present invention relates to novel benzimidazole compounds, represented by general formula (I) in which o is 0, 1, 2 or 3; R1 represents an alkyl group, a phenyl group, or a monocyclic heterocyclic group, which groups may be substituted one or more times with substituents selected from alkyl, cycloalkyl, cycloalkyl-alkyl, alkoxy, halogen, trifluoromethyl, cyano, amino and nitro; or R1 represents a cyano group or a group of the formula -alkyl-CO2R2, alkenyl-CO2R2, —CO—R2, —CO2(CH2)mR2, or —C(R3)═N—OR2, R11 represents a group of formula —CO2—R9, or R11 represents a group of general formula (II) in which n is 0, 1, 2 or 3; or R11 may represent a group of general formula (III), in which n is 0, 1, 2 or 3; the novel compounds of the invention are useful in the treatment of central nervous system diseases and disorders, which are responsive to modulation of the GABAA receptor complex, such as for example anxiety, sleep disorders, anaestesia, memory disorders, and epilepsia or other convulsive disorders.

  本发明涉及一种新颖的苯并咪唑化合物，其表示为一般式(I)，其中o为0、1、2或3；R1代表烷基、苯基或单环杂环基，这些基团可以被来自烷基、环烷基、环烷基烷基、烷氧基、卤素、三氟甲基、氰基、氨基和硝基的取代基取代一次或多次；或者R1代表氰基或者具有式-烷基- R2、烯基- R2、—CO—R2、—CO2(CH2)mR2或—C(R3)HN—OR2的基团，R11代表式— —R9的基团，或者R11代表一般式(II)中n为0、1、2或3的基团；或者R11可以表示一般式(III)中n为0、1、2或3的基团；本发明的新化合物在用于治疗对GABAA受体复合物调节敏感的中枢神经系统疾病和紊乱方面具有用途，例如焦虑、睡眠障碍、麻醉、记忆障碍、癫痫或其他惊厥症。
• Benzimidazole derivatives and their use for modulating the gaba-alpha receptor complex
  申请人：Teuber Lene

  公开号：US20090062304A1

  公开（公告）日：2009-03-05

  This invention relates to novel benzimidazole derivatives, pharmaceutical compositions containing these compounds, and methods of treatment therewith. The compounds of the invention are useful in the treatment of central nervous system diseases and disorders, which are responsive to modulation of the GABA A receptor complex, and in particular for combating anxiety and related diseases.

  本发明涉及新型苯并咪唑衍生物，含有这些化合物的药物组合物，以及使用这些化合物进行治疗的方法。本发明的化合物在治疗对GABA-A受体复合物的调节敏感的中枢神经系统疾病和紊乱方面是有用的，特别是用于对抗焦虑和相关疾病。
• Technical field
  申请人：NeuroSearch A/S

  公开号：US20030166638A1

  公开（公告）日：2003-09-04

  Chemical compounds of the formula 1 as well as pharmaceutical compositions containing them and methods for their use in the treatment of disorders and diseases responsive to modulation of the GABA A receptor complex of the central nervous system, such disorders and diseases including anxiety, sleep disorders, anesthesia, memory disorders, and epilepsy and other convulsive disorders.

  化学式为1的化合物，以及含有它们的制药组合物和使用它们治疗对中枢神经系统的GABAA受体复合物调节敏感的疾病和疾病的方法，这些疾病包括焦虑症、睡眠障碍、麻醉、记忆障碍、癫痫和其他惊厥性疾病。
• 1-phenyl-benzimidazole compounds and their use as GABA-A receptor modulators
  申请人：NeuroSearch A/S

  公开号：US06503925B1

  公开（公告）日：2003-01-07

  Chemical compounds of the formula as well as pharmaceutical compositions containing them and methods for their use in the treatment of disorders and diseases responsive to modulation of the GABAA receptor complex of the central nervous system, such disorders and diseases including anxiety, sleep disorders, anesthesia, memory disorders, and epilepsy and other convulsive disorders.

  化学式为的化合物以及包含它们的药物组合物，以及它们在治疗对中枢神经系统的GABAA受体复合物进行调节响应的紊乱和疾病方面的使用方法，这些紊乱和疾病包括焦虑、睡眠障碍、麻醉、记忆障碍、癫痫和其他惊厥性紊乱。